Life-Sciences Successfully invest during uncertain times

Life-Sciences Investment Series, October 2022

Successfully investing in early life science assets, such as medical device projects, diagnostics, digital therapeutics or drug therapies, requires conducting thorough scientific due diligence, monitoring the development plan execution, and implementing a development risk assessment & mitigation plan.

Besides the challenging environment, we observed that this era is appropriate to invest in Life Science assets successfully. After interacting with several Biotech founders, we consistently observed that they need the investors’ advice and network, as much as the funds.

More in our October 2022 issue of Life-Sciences Investment Series


No responses yet

Leave a Reply

Your email address will not be published. Required fields are marked *